|
FY2026
12 months to May 2, 2026
|
FY2025
12 months to May 3, 2025
|
FY2024
12 months to Apr 27, 2024
|
FY2023
12 months to Apr 29, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product sales | |||||
| Product engineering services | |||||
| IP license | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Product sales | |||||
| Product engineering services | |||||
| IP license | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment charges | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income, net | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share: | |||||
| Basic (in US dollars per share) | |||||
| Diluted (in US dollars per share) | |||||
| Weighted-average shares used in computing net income (loss) per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...